Please login to the form below
pediatrics
This page shows the latest pediatrics news and features for those working in and with pharma, biotech and healthcare.
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more
Orchard gains rare disease status for ex-GSK therapy. Orchard Therapeutics has been granted an FDA Rare Pediatric Disease Designation for its rare disease gene therapy candidate OTL-200, which it
Latest news
-
Dr Reddy's brings its generics portfolio to France
Meanwhile, in its home country it is targeting a number of therapy areas, having agreed a 118m deal with UCB in 2015 to acquire a portfolio of dermatology, respiratory and pediatric
-
Lilly pilots enhanced online trial information
The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with
-
Biogen buys into Ionis' nusinersen after positive phase III trial
Potential blockbuster spinal muscular atrophy drug will be filed “in the coming months”
-
Celebrating excellence
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
-
PMEA 2015 win for Novo's Changing Diabetes in Children
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolsecent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
Dr Reddy's brings its generics portfolio to France
Lilly pilots enhanced online trial information
Biogen buys into Ionis' nusinersen after positive phase III trial
Celebrating excellence
PMEA 2015 win for Novo's Changing Diabetes in Children
More from news
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
The trials and tribulations of rare opportunities
Preclinical trials of rare disease drugs are challenging, said Jeffrey Keefer, MD VP, Medical Strategy Head of Pediatric and Rare Disease at IQVIA.
-
Implementing eHealth innovation
The first results from the global, five-year observational study in children with growth disorders was presented at the 10th International Meeting of Pediatric Endocrinology in September 2017.
-
Case study: The KiDS project in India and Brazil
Client:Sanofi, the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes. ... In response to this, the KiDS project was established by the International Diabetes Federation and the International Society for
-
Paging Dr Millennial
Almost 50% of the world's population today is under 25 years old, which means that family planning, women's health and pediatrics will be growing elements of the world's
-
Pharma deals in August 2015
In 2012 the PRV programme was extended to include rare pediatric diseases and the emergence of trading in PRVs was noted in our last annual Deal Watch report.
The trials and tribulations of rare opportunities
Implementing eHealth innovation
Case study: The KiDS project in India and Brazil
Paging Dr Millennial
Pharma deals in August 2015
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
BMS appoints oncology development head
As a trained pediatric oncologist, Fouad brings to this role exceptional clinical experience and an unwavering commitment to patients.
-
Dr Andrew Mulberg moves from FDA to Amicus Therapeutics
Dr Mulberg is a pediatric gastroenterologist, and was attending physician and fellowship director in gastroenterology and hepatology for The Children's Hospital of Philadelphia between 1993 and 2001. ... He is currently the board chairman and member of
-
Former PEPFAR head Mark Dybul to lead the Global Fund
In addition to his new post, Dr Dybul currently serves as a director on several executive and advisory boards of health organisations, including Malaria No More, the Elizabeth Glaser Pediatric AIDS
BMS appoints oncology development head
Dr Andrew Mulberg moves from FDA to Amicus Therapeutics
Former PEPFAR head Mark Dybul to lead the Global Fund
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Live Webinar: Making Wearable Technology Scalable and Adoptable
EVP at Myant Inc., will join Natalie Yeadon, to share her insights on “Textile Computing,” including how it can be used for remote monitoring, health assessments, pediatric and maternal care, temperature
-
Gamification for patient care, medical education, and virtual engagement
pediatric care, as well as for medical education, training, event engagement, and more.
-
Building Better Access to Pediatric Care Through Telehealth
Jeannie Chen, Head of Clinical Operations and People at Hazel Health, shares her insights on telemedicine and virtual care as means to improve healthcare access and equity among school-aged children. We also dive into the secondary effects of
-
If our patients are diverse, why are clinical trials so white?
families, Beck et al, Pediatric Research, 87, 227-234(2020).
-
Mastering the precision medicine opportunity
Last year the FDA made a pioneering move in this space and approved Keytruda for use in adult and pediatric patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- Live Webinar: Making Wearable Technology Scalable and Adoptable
- Live Webinar: Transforming the Future of Health & Aging from a Global Health & Social Impact Approach
- Investors respond positively to “strong” Eli Lilly results
- Sanofi to buy mRNA tech partner, Translate Bio, for $3.2bn
- Novartis to proceed with phase 3 trial for intrathecal OAV-101 in older SMA patients
- Ask the writers: Transitioning from academia to medical writing
No results were found
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Ask the writers: Transitioning from academia to medical writing
- Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
- Strategic launch planning: familiar framework, new mindset
- By James Aird...
- Guide
- How to embrace behavioural science principles in healthcare MR...
